Why everyone from doctors to investors is excited about this treatment? In this edition of LEARNING OF THE WEEK, In today’s newsletter, we dive into the GLP-1 buzz, why doctors, patients, and even investors are all talking about this game-changing treatment. From Hollywood to Silicon Valley, from doctors’ clinics to dinner table chats, GLP-1 is the hot […]
Inside the GLP-1 frenzy Read More »
SEBI Registered Research Analyst
SEBI Registration No: INH000013712
BASL Membership ID: 5922
Bastion CORE is an independent equity research platform providing unbiased equity research to its subscribers. We do not recommend investing in any company covered and published by us as a part of our research activity to run Bastion CORE. The subscriber is solely responsible for all investment and financial decisions he takes and is requested to conduct due diligence himself/herself or consult his/her financial advisor before taking any action. Please note that Bastion Research takes no responsibility for the financial impact created due to the decision taken by the subscriber. If one is unwilling to accept the above-mentioned facts, we request them to not subscribe to Bastion CORE.Â
Investment in Securities Market are subject to market risks. Read all related documents carefully before investing. The securities quoted are for illustration only and are not recommendatory. Registration granted by SEBI, membership of a SEBI recognized supervisory body (if any) and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.
Copyright © 2024 Bastion Research
